Clinical Trial Detail

NCT ID NCT01187199
Title Phase I Trial of Bevacizumab and Temsirolimus in Combination With 1) Carboplatin, 2) Paclitaxel, 3) Sorafenib for the Treatment of Advanced Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

Advanced Solid Tumor

Therapies

Bevacizumab

Paclitaxel

Carboplatin

Sorafenib

Temsirolimus

Age Groups: child senior adult

No variant requirements are available.